BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 29724919)

  • 1. Trend in rifampicin-, multidrug- and extensively drug-resistant tuberculosis in Italy, 2009-2016.
    Mustazzolu A; Borroni E; Cirillo DM; Giannoni F; Iacobino A; ; Fattorini L
    Eur Respir J; 2018 Jul; 52(1):. PubMed ID: 29724919
    [No Abstract]   [Full Text] [Related]  

  • 2. Multidrug-resistant/extensively drug-resistant tuberculosis in Greece: predominance of Mycobacterium tuberculosis genotypes endemic in the Former Soviet Union countries.
    Ioannidis P; van Soolingen D; Mokrousov I; Papaventsis D; Karabela S; Konstantinidou E; Marinou I; Nikolaou S; Kanavaki S; Mantadakis E; Samonis G; Anthony R; Vogiatzakis E
    Clin Microbiol Infect; 2017 Dec; 23(12):1002-1004. PubMed ID: 28698038
    [No Abstract]   [Full Text] [Related]  

  • 3. Challenges and Outlooks in Multi-drug Resistant Tuberculosis.
    Caminero Luna JA
    Arch Bronconeumol; 2017 Aug; 53(8):417-418. PubMed ID: 28314633
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug-resistant tuberculosis plagues India.
    Sibbald B
    CMAJ; 2016 Mar; 188(5):322-324. PubMed ID: 26883311
    [No Abstract]   [Full Text] [Related]  

  • 5. Totally drug-resistant and extremely drug-resistant tuberculosis: the same disease?
    Migliori GB; Centis R; D'Ambrosio L; Spanevello A; Borroni E; Cirillo DM; Sotgiu G
    Clin Infect Dis; 2012 May; 54(9):1379-80. PubMed ID: 22492321
    [No Abstract]   [Full Text] [Related]  

  • 6. Outbreak of pre- and extensively drug-resistant tuberculosis in northern Italy: urgency of cross-border, multidimensional, surveillance systems.
    Villa S; Tagliani E; Borroni E; Castellotti PF; Ferrarese M; Ghodousi A; Lamberti A; Senatore S; Faccini M; Cirillo DM; Codecasa LR
    Eur Respir J; 2021 Sep; 58(3):. PubMed ID: 34049944
    [No Abstract]   [Full Text] [Related]  

  • 7. What is new in the WHO consolidated guidelines on drug-resistant tuberculosis treatment?
    Sharma SK; Dheda K
    Indian J Med Res; 2019 Mar; 149(3):309-312. PubMed ID: 31249191
    [No Abstract]   [Full Text] [Related]  

  • 8. Concomitant increases in spectrum and level of drug resistance in Mycobacterium tuberculosis isolates.
    Sun Z; Zhang J; Song H; Zhang X; Li Y; Tian M; Liu Y; Zhao Y; Li C
    Int J Tuberc Lung Dis; 2010 Nov; 14(11):1436-41, i. PubMed ID: 20937184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyrazinamide resistance in Mycobacterium tuberculosis arises after rifampicin and fluoroquinolone resistance.
    Alame-Emane AK; Xu P; Pierre-Audigier C; Cadet-Daniel V; Shen X; Sraouia M; Siawaya JF; Takiff H; Gao Q; Gicquel B
    Int J Tuberc Lung Dis; 2015 Jun; 19(6):679-84. PubMed ID: 25946359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Belarus and drug-resistant tuberculosis.
    Bull World Health Organ; 2019 Dec; 97(12):795-796. PubMed ID: 31819286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic and genotypic analysis of multidrug-resistant tuberculosis in Ethiopia.
    Agonafir M; Lemma E; Wolde-Meskel D; Goshu S; Santhanam A; Girmachew F; Demissie D; Getahun M; Gebeyehu M; van Soolingen D
    Int J Tuberc Lung Dis; 2010 Oct; 14(10):1259-65. PubMed ID: 20843416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to anti-tuberculosis medications in the Horn of Africa.
    Ollé-Goig JE; Codina-Grau G; Martín-Casabona N
    Int J Tuberc Lung Dis; 2011 Mar; 15(3):414-6. PubMed ID: 21333114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in discovery of new drugs for tuberculosis therapy.
    Riccardi G; Pasca MR
    J Antibiot (Tokyo); 2014 Sep; 67(9):655-9. PubMed ID: 25095807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unsexy tuberculosis.
    Reichman LB
    Lancet; 2009 Jan; 373(9657):28. PubMed ID: 19121719
    [No Abstract]   [Full Text] [Related]  

  • 15. New definitions of pre-extensively and extensively drug-resistant tuberculosis: update from the World Health Organization.
    Viney K; Linh NN; Gegia M; Zignol M; Glaziou P; Ismail N; Kasaeva T; Mirzayev F
    Eur Respir J; 2021 Apr; 57(4):. PubMed ID: 33833074
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug-resistant tuberculosis: reality and potential threat.
    Lalloo UG
    Int J Tuberc Lung Dis; 2010 Mar; 14(3):255-8. PubMed ID: 20132610
    [No Abstract]   [Full Text] [Related]  

  • 17. The imminent threat of multidrug-resistant tuberculosis in Singapore.
    Chee CB; Khin-Mar KW; Cutter J; Wang YT
    Singapore Med J; 2012 Apr; 53(4):238-40. PubMed ID: 22511044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First report of extensively drug-resistant Mycobacterium tuberculosis (XDR-TB) infection in Kuwait.
    Mokaddas E; Ahmad S; Eldeen HS; Zaglul H; Al-Mutairi NM; Al-Otaibi A
    J Infect Public Health; 2021 Nov; 14(11):1612-1613. PubMed ID: 34624715
    [No Abstract]   [Full Text] [Related]  

  • 19. Tuberculosis in migrants from 106 countries to Italy, 2008-2014.
    Fattorini L; Mustazzolu A; Borroni E; Piccaro G; Giannoni F; Cirillo DM;
    Eur Respir J; 2016 Apr; 47(4):1273-6. PubMed ID: 26846829
    [No Abstract]   [Full Text] [Related]  

  • 20. Multidrug-Resistant Tuberculosis in U.S.-Bound Immigrants and Refugees.
    Liu Y; Posey DL; Yang Q; Weinberg MS; Maloney SA; Lambert LA; Ortega LS; Marano N; Cetron MS; Phares CR
    Ann Am Thorac Soc; 2022 Jun; 19(6):943-951. PubMed ID: 34941475
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.